Sphere Fluidics to Join UKTI Synthetic Biology Mission to San Francisco


Dr Rob Marchmont (Commercial Director of Sphere Fluidics) will be joining a UK Trade and Investment Mission to San Francisco (USA) between 13th-17th November 2013. A specially-selected group of UK companies will meet US firms and investors which have an interest in the synthetic biology area. “Sphere Fluidics has novel technology that can analyse millions of cells and (molecules produced by) their synthetic pathways and we would be interested to develop collaborations with leading US firms in this sector”. says Dr Marchmont. Some conference information can be found here.